Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07094542 · ClinicalTrials.gov registry record · Phase 2
Jaw Muscle Pain Post Wisdom Molar Surgery
A Phase 2 study, sponsored by Rutgers, The State University of New Jersey.
- Not yet
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
NCT07094542 is a Phase 2 study that has not yet begun recruiting, run by Rutgers, The State University of New Jersey. The registered enrollment target is 80 participants.
The verdict
NCT07094542, a Phase 2 study, has not yet begun recruiting, sponsored by Rutgers, The State University of New Jersey.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
Study Summary
The proposed design is a triple-blind, placebo-controlled randomized prospective phase II trial to assess the feasibility of employing the Temporo-masseteric Nerve Block (TMNB) injection to decrease jaw muscle pain, overall pain, improve mouth opening and minimize pain medication consumption. 80 participants undergoing lower third molar removal under sedation will be enrolled. Those who develop significant jaw muscle pain on the following day will be randomized to receive either the TMNB injection or a placebo. Daily ecological momentary assessments (EMAs) will be collected reflecting elements of patient experience for all participants. On Day 8, participants return for an end-of-study evaluation and return their unused pain medications. Up to 40 participants who are randomized to receive TMNB/placebo will be recruited to participate in a qualitative interview regarding their experience.
Interventions
- DRUG Temporo-masseteric Nerve Block Injection
- DRUG Oral Pain Medications only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-09 |
| Est. Completion | 2030-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07094542
The ClinicalTrials.gov registry entry for NCT07094542 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Temporo-masseteric Nerve Block Injection is the first listed.
NCT07094542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07094542 about?
NCT07094542 is a clinical study titled "Jaw Muscle Pain Post Wisdom Molar Surgery". The proposed design is a triple-blind, placebo-controlled randomized prospective phase II trial to assess the feasibility of employing the Temporo-masseteric Nerve Block (TMNB) injection to decrease jaw muscle pain, overall pain, improve mouth opening and minimize pain medication consumption. 80 par...
What is the current status of trial NCT07094542?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2026-09. Estimated completion is 2030-05.
What interventions are being tested in trial NCT07094542?
The interventions under investigation include: Temporo-masseteric Nerve Block Injection (DRUG), Oral Pain Medications only (DRUG).
Who is sponsoring clinical trial NCT07094542?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.